Cardiac Surgery
Controversies in revascularization for stable coronary artery disease
30 Mar, 2021 | 02:49h | UTCControversies in revascularisation for stable coronary artery disease – Clinical Medicine Journal
Long-term outcomes of patients undergoing the Ross procedure
21 Mar, 2021 | 21:42h | UTCCommentaries: Ross Procedure Done Well Holds Up Over Time – TCTMD AND Long-Term Outcomes of the Ross Procedure – American College of Cardiology
Guideline: SARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery
23 Mar, 2021 | 02:33h | UTCSARS‐CoV‐2 infection, COVID‐19 and timing of elective surgery – Anaesthesia
Commentary on Twitter
Our research has underpinned key recommendations in new guidance on SARS-CoV-2 infection & elective surgery from @Assoc_Anaes & @RCoANews & @RCSnews.
This guideline can act as a template for policy makers in other countries!
?https://t.co/kKgJXFf0vd pic.twitter.com/mJRasJTJws
— COVIDSurg (@CovidSurg) March 20, 2021
Platelet tests pre-CABG may safely shorten washout waits, cut costs
16 Mar, 2021 | 01:44h | UTCPlatelet Tests Pre-CABG May Safely Shorten Washout Waits, Cut Costs – TCTMD
M-A: Angiographic Patency of Coronary Artery Bypass Conduits
12 Mar, 2021 | 08:10h | UTC
Prevalence of bicuspid aortic valve and associated aortopathy in newborns in Copenhagen, Denmark
21 Feb, 2021 | 21:58h | UTCPrevalence of Bicuspid Aortic Valve and Associated Aortopathy in Newborns in Copenhagen, Denmark – JAMA (link to abstract – $ for full-text)
Commentary on Twitter
In this population epi study the prevalence of bicuspid aortic valve (BAV) among newborns in Copenhagen was 0.77%; aortopathy incl. coarctation was common, suggesting that it represents a fetal malformation https://t.co/xqUBzQn9NA @HenningBundgaa1 @jamapediatrics
— JAMA (@JAMA_current) February 11, 2021
Expert consensus of data elements for collection for enhanced recovery after cardiac surgery
21 Feb, 2021 | 21:53h | UTCRelated: Enhanced Recovery After Surgery (ERAS) Guidelines for Perioperative Care in Cardiac Surgery (guideline and commentary) AND Enhanced Recovery After Cardiac Surgery (ERAS Cardiac) Recommendations: An Important First Step—But There Is Much Work to Be Done – Cardiothoracic and Vascular Anesthesia (free)
See also: Enhanced Recovery After Surgery (ERAS) Society Guidelines
Commentary on Twitter
Just published in @WorldJSurg
"Expert Consensus of Data Elements for Collection for Enhanced Recovery After Cardiac Surgery"
Available for free download here https://t.co/7L4evdqg0G pic.twitter.com/3XyKt6P6wv
— ERAS Society (@ErasSociety) February 21, 2021
European position paper on the management of patients with patent foramen ovale. Part II – Decompression sickness, migraine, arterial deoxygenation syndromes, and select high-risk clinical conditions
18 Feb, 2021 | 02:36h | UTC
Observational study suggests aspirin is a better choice than warfarin for children who have undergone Fontan surgery
16 Feb, 2021 | 02:03h | UTCCommentary: Aspirin preferred to prevent blood clots in kids after heart surgery – Murdoch Children’s Research Institute
Commentary on Twitter
I have been blown away with the interest in my paper – Asprin vs warfarin after Fontan surgery ❤️3 commentaries so far, highlighting the strengths of our work and advocating for more research in this growing population @MCRI_for_kids @UniMelbMDHS @nhmrc https://t.co/nveDaqM6r3
— Dr Chantal Attard (@Chantal_Attard) February 4, 2021
RCT: Dobutamine-sparing vs. dobutamine-to-all strategy in cardiac surgery
9 Feb, 2021 | 00:57h | UTC
Randomized trial: Conservative fluid management strategy vs. usual care in participants after cardiac surgery
1 Feb, 2021 | 01:39h | UTC
Randomized trial: Continuous postoperative pericardial flushing reduces postoperative bleeding after coronary artery bypass grafting
29 Jan, 2021 | 01:28h | UTC
Meta-analysis: Minimally invasive surgery versus transcatheter aortic valve replacement
27 Jan, 2021 | 01:00h | UTCCommentary: TAVI vs Minimally Invasive AVR Yields Surprising Findings: Meta-analysis – TCTMD
Commentary on Twitter
Comprehensive systematic review and meta-analysis of miniAVR vs #TAVR. Important in the context of 'lifetime management of valves'. Thank you for the opportunity. @Shoukmed @ahmedsayed8991 @BrighamSurgery @BrighamThoracic CC:@TSRA_official @STS_CTsurgery @AATSED @ThoracicsCanada https://t.co/T1XDrebl8U pic.twitter.com/5E5eOLherA
— Sameer Hirji (@Hirji1987) January 21, 2021
Another study suggests fluoroquinolone use may increase the risk of development of aortic aneurysms
12 Jan, 2021 | 01:38h | UTCAssociation of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm – JAMA Surgery (free for a limited period)
Commentaries: Fluoroquinolones and Aortic Disease—Is It Time to Broaden the Warning? – JAMA (free for a limited period) AND Study links fluoroquinolones to higher risk of aneurysm – CIDRAP AND Analysis Links Fluoroquinolones to Increased Aortic Aneurysm Risk – Physician’s Weekly
2020 ACC/AHA Guideline for the management of patients with valvular heart disease
18 Dec, 2020 | 09:45h | UTCNews release: Updated guideline for heart valve disease spotlights less invasive treatments
Key Perspectives: Part 1
Key Perspectives: Part 2
Key Perspectives: Part 3
Commentary on Twitter
New ACC/@American_Heart Guideline for the Management of patients with #cvVHD includes expanded treatment options; recommends less invasive interventions, when possible; and stresses the importance of #SharedDecisionMaking. Read it in #JACC: https://t.co/g9RE9buXNC pic.twitter.com/jnwt8d5QC7
— JACC Journals (@JACCJournals) December 17, 2020
Review: Mechanical complications of acute myocardial infarction
11 Dec, 2020 | 09:19h | UTCMechanical Complications of Acute Myocardial Infarction: A Review – JAMA Cardiology
Videos: Acute Rupture of Left Ventricular Aneurysm AND Ventricular Septal Rupture AND Papillary Muscle Rupture
Review: Perioperative venous thromboembolism prophylaxis
3 Dec, 2020 | 08:28h | UTCPerioperative Venous Thromboembolism Prophylaxis – Mayo Clinic Proceedings
#AHA20 – Randomized trial: In patients with atrial fibrillation and a bioprosthetic mitral valve, Rivaroxaban (20 mg) was noninferior to Warfarin (INR 2-3) for death, MACE, or major bleeding at 12 months
16 Nov, 2020 | 02:01h | UTCRivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve – New England Journal of Medicine (link to abstract – $ for full-text)
News Release: Rivaroxaban may be as effective as warfarin for bioprosthetic mitral valves, AF – American Heart Association
Commentaries: Rivaroxaban an Option for Patients with Bioprosthetic Mitral Valves and A-fib – TCTMD AND Rivaroxaban for Valvular Heart Disease and Atrial Fibrillation – RIVER – American College of Cardiology AND Rivaroxaban Noninferior to Warfarin for Atrial Fibrillation in Patients with Bioprosthetic Mitral Valves – NEJM Journal Watch
Commentary on Twitter
In a trial comparing rivaroxaban with dose-adjusted warfarin, rivaroxaban was noninferior to warfarin with respect to the mean time until the primary outcome of death, major cardiovascular events, or major bleeding at 12 months. #AHA20
— NEJM (@NEJM) November 14, 2020
Safe surgery: A cluster randomized trial showed that the implementation of control charts with feedback on indicators to surgical teams was associated with concomitant reductions in major adverse events in patients
9 Nov, 2020 | 01:23h | UTC
JACC Review: Evaluation and management of patients with stable angina. Based on large clinical trials, medical therapy rather than revascularization is the initial management strategy for most patients
6 Nov, 2020 | 09:43h | UTCEvaluation and Management of Patients With Stable Angina: Beyond the Ischemia Paradigm: JACC State-of-the-Art Review – Journal of the American College of Cardiology (free for a limited period)
Summary: Evaluation and Management of Patients With Stable Angina – American College of Cardiology
Association between industry payments to physicians and device selection in ICD implantation
4 Nov, 2020 | 09:40h | UTCAssociation Between Industry Payments to Physicians and Device Selection in ICD Implantation – JAMA (free for a limited period)
Editorial: Reconsidering Health Care Fraud and Abuse Laws (free for a limited period)
Commentary on Twitter
More evidence that payments from industry to physicians influence clinical decisions. Great paper led by @AmarMD99 in @YaleCardiology shows that patients most likely to receive ICD/CRD made by manufacturer that provided largest payments to their physician https://t.co/P1Hh2VAxur
— Joseph Ross (@jsross119) November 3, 2020
Review: Management of common postoperative complications
4 Nov, 2020 | 09:26h | UTCManagement of Common Postoperative Complications – Mayo Clinic Proceedings
The ‘Ten Commandments’ in the new ESC Adult Congenital Heart Disease Guidelines
29 Oct, 2020 | 08:59h | UTCOriginal guideline and commentaries: 2020 ESC Guidelines for the management of adult congenital heart disease
[Abstract Only] Redevelopment and validation of the SYNTAX score II to predict the benefit of PCI vs. CABG in patients with complex coronary artery disease
23 Oct, 2020 | 08:59h | UTCSee calculator: SYNTAX Score II calculator
Meta-analysis: Overall and cause-specific mortality in randomized clinical trials comparing percutaneous interventions with coronary bypass surgery
14 Oct, 2020 | 09:16h | UTCOverall and Cause-Specific Mortality in Randomized Clinical Trials Comparing Percutaneous Interventions With Coronary Bypass Surgery: A Meta-analysis – JAMA Internal Medicine (free for a limited period)
Commentary on Twitter
In an analysis of 23 randomized trials comparing CABG and PCI, PCI was associated with higher rates of cardiac, non-cardiac, and all-cause mortality. All-cause mortality should be used as endpoint in revascularization trials https://t.co/DBSvVkr3EK
— JAMA Internal Medicine (@JAMAInternalMed) October 12, 2020